John J Mason

Array ( [id] => 5759615 [patent_doc_number] => 20060210560 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'TNF receptor action modulaton' [patent_app_type] => utility [patent_app_number] => 11/404081 [patent_app_country] => US [patent_app_date] => 2006-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7093 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20060210560.pdf [firstpage_image] =>[orig_patent_app_number] => 11404081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5842187 [patent_doc_number] => 20060121018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Methods and compositions for targeting proteins across the blood brain barrier' [patent_app_type] => utility [patent_app_number] => 11/234876 [patent_app_country] => US [patent_app_date] => 2005-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8692 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20060121018.pdf [firstpage_image] =>[orig_patent_app_number] => 11234876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 856943 [patent_doc_number] => 07375203 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-20 [patent_title] => 'Canine cold- and menthol-sensitive receptor 1' [patent_app_type] => utility [patent_app_number] => 11/099855 [patent_app_country] => US [patent_app_date] => 2005-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 22359 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/375/07375203.pdf [firstpage_image] =>[orig_patent_app_number] => 11099855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5738429 [patent_doc_number] => 20060008819 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Novel 38594, 57312, 53659, 57250, 63760, 49938, 32146, 57259, 67118, 67067, 62092, FBH58295FL, 57255, and 57255alt molecules and uses therefor' [patent_app_type] => utility [patent_app_number] => 11/043889 [patent_app_country] => US [patent_app_date] => 2005-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 174669 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20060008819.pdf [firstpage_image] =>[orig_patent_app_number] => 11043889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7074803 [patent_doc_number] => 20050148071 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'Production of tyrosine hydroxylase positive neurons' [patent_app_type] => utility [patent_app_number] => 10/985849 [patent_app_country] => US [patent_app_date] => 2004-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6371 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20050148071.pdf [firstpage_image] =>[orig_patent_app_number] => 10985849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7143640 [patent_doc_number] => 20050118565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Systems and methods for assessing neuronal degeneration' [patent_app_type] => utility [patent_app_number] => 10/966405 [patent_app_country] => US [patent_app_date] => 2004-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5806 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20050118565.pdf [firstpage_image] =>[orig_patent_app_number] => 10966405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7211829 [patent_doc_number] => 20050054049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Novel human transporter proteins and polynucleotides encoding the same' [patent_app_type] => utility [patent_app_number] => 10/924751 [patent_app_country] => US [patent_app_date] => 2004-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9243 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054049.pdf [firstpage_image] =>[orig_patent_app_number] => 10924751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5880464 [patent_doc_number] => 20060029546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-09 [patent_title] => 'Materials and methods for identifying anti-schizophrenic agents' [patent_app_type] => utility [patent_app_number] => 10/912971 [patent_app_country] => US [patent_app_date] => 2004-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 28610 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20060029546.pdf [firstpage_image] =>[orig_patent_app_number] => 10912971 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7061703 [patent_doc_number] => 20050004065 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Hypoxia regulated genes' [patent_app_type] => utility [patent_app_number] => 10/857942 [patent_app_country] => US [patent_app_date] => 2004-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 29630 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20050004065.pdf [firstpage_image] =>[orig_patent_app_number] => 10857942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7263218 [patent_doc_number] => 20040241639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Human tachykinin-related splice variants and compositions thereof' [patent_app_type] => new [patent_app_number] => 10/476591 [patent_app_country] => US [patent_app_date] => 2004-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14026 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20040241639.pdf [firstpage_image] =>[orig_patent_app_number] => 10476591 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6966021 [patent_doc_number] => 20050232918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Differentially expressed genes associated with obesity and type 2 diabetes' [patent_app_type] => utility [patent_app_number] => 10/826448 [patent_app_country] => US [patent_app_date] => 2004-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 19214 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20050232918.pdf [firstpage_image] =>[orig_patent_app_number] => 10826448 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7020023 [patent_doc_number] => 20050222042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Method for modification of NMDA receptors through inhibition of Src' [patent_app_type] => utility [patent_app_number] => 10/814109 [patent_app_country] => US [patent_app_date] => 2004-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12563 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222042.pdf [firstpage_image] =>[orig_patent_app_number] => 10814109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7185007 [patent_doc_number] => 20050191710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'Method for labeling a membrane-localized protein' [patent_app_type] => utility [patent_app_number] => 10/790273 [patent_app_country] => US [patent_app_date] => 2004-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9386 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20050191710.pdf [firstpage_image] =>[orig_patent_app_number] => 10790273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7276620 [patent_doc_number] => 20040236071 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Methods and compositions for the treatment of diseases associated with signal transduction aberrations' [patent_app_type] => new [patent_app_number] => 10/786774 [patent_app_country] => US [patent_app_date] => 2004-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 27726 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20040236071.pdf [firstpage_image] =>[orig_patent_app_number] => 10786774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7088527 [patent_doc_number] => 20050008639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Methods of modulating homing of T cell by interruption of chemokine/chemokine receptor signaling' [patent_app_type] => utility [patent_app_number] => 10/777883 [patent_app_country] => US [patent_app_date] => 2004-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 16992 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20050008639.pdf [firstpage_image] =>[orig_patent_app_number] => 10777883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7311055 [patent_doc_number] => 20040143096 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Mammalian cytokine-like factor 7' [patent_app_type] => new [patent_app_number] => 10/772985 [patent_app_country] => US [patent_app_date] => 2004-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14240 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20040143096.pdf [firstpage_image] =>[orig_patent_app_number] => 10772985 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7426873 [patent_doc_number] => 20040265819 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Kidney-specific urate transporter and gene thereof' [patent_app_type] => new [patent_app_number] => 10/485236 [patent_app_country] => US [patent_app_date] => 2004-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 4778 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20040265819.pdf [firstpage_image] =>[orig_patent_app_number] => 10485236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7347625 [patent_doc_number] => 20040248099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Use of intermediate -conductance potassium channels and modulators for diagnosing and treating diseases having disturbed keratinocyte activity' [patent_app_type] => new [patent_app_number] => 10/451805 [patent_app_country] => US [patent_app_date] => 2004-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 26814 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248099.pdf [firstpage_image] =>[orig_patent_app_number] => 10451805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7374863 [patent_doc_number] => 20040219600 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Method for determining sensitivity to environmental toxins and susceptibility to parkinson\'s disease' [patent_app_type] => new [patent_app_number] => 10/734372 [patent_app_country] => US [patent_app_date] => 2003-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16094 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20040219600.pdf [firstpage_image] =>[orig_patent_app_number] => 10734372 [rel_patent_id] =>[rel_patent_doc_number] =>)